Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence in pharmaceutical research and development.

Future medicinal chemistry·2018
Same author

Enzyme function and its evolution.

Current opinion in structural biology·2017
Same author

DichroMatch at the protein circular dichroism data bank (DM@PCDDB): A web-based tool for identifying protein nearest neighbors using circular dichroism spectroscopy.

Protein science : a publication of the Protein Society·2017
Same author

Collision energy dependence of state-to-state differential cross sections for rotationally inelastic scattering of H<sub>2</sub>O by He.

Physical chemistry chemical physics : PCCP·2017
Same author

PDB2CD: a web-based application for the generation of circular dichroism spectra from protein atomic coordinates.

Bioinformatics (Oxford, England)·2016
Same author

PCDDB: new developments at the Protein Circular Dichroism Data Bank.

Nucleic acids research·2016

Related Experiment Video

Updated: May 10, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Predicting the protein targets for athletic performance-enhancing substances.

Lazaros Mavridis1, John Bo Mitchell

  • 1Biomedical Sciences Research Complex and EaStCHEM School of Chemistry, Purdie Building, University of St Andrews, North Haugh, St Andrews, Scotland KY16 9ST, UK. lm213@st-andrews.ac.uk.

Journal of Cheminformatics
|June 27, 2013
PubMed
Summary
This summary is machine-generated.

This study developed a machine learning model using ChEMBL data to predict performance-enhancing substances relevant to anti-doping efforts. The approach accurately identifies compounds and their interactions with doping targets, aiding in the detection of prohibited substances.

More Related Videos

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions
06:50

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions

Published on: January 26, 2024

A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

Related Experiment Videos

Last Updated: May 10, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions
06:50

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions

Published on: January 26, 2024

A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Anti-doping science

Background:

  • The World Anti-Doping Agency (WADA) maintains a Prohibited List of banned substances and methods.
  • Automated, fast, and cost-effective identification of performance-enhancing substances is needed.
  • Existing methods for identifying doping agents can be improved through advanced computational approaches.

Purpose of the Study:

  • To build a database model using ChEMBL experimental data (structure and activity) for predicting doping-relevant substance interactions.
  • To identify on-target and off-target interactions of compounds with targets relevant to sport doping.
  • To develop a computational tool for the automated detection of potential doping agents.

Main Methods:

  • Screening the ChEMBL database and filtering activity records (Ki, Kd, EC50, etc.) to define "active" and "inactive" compounds.
  • Applying structure-based clustering to group compounds with similar scaffolds and bioactivities.
  • Utilizing the Parzen-Rosenblatt machine learning approach for predictive modeling and validation.

Main Results:

  • Refined families of compounds were created, sharing common scaffolds and bioactivities against specific targets.
  • The machine learning model demonstrated significant increases in prediction accuracy compared to baseline methods.
  • Validation showed high accuracy, with 66.98% of queries correctly predicting the parent family and 87.25% within the top four predictions.

Conclusions:

  • The validated machine learning approach effectively predicts compound families and their bioactivities.
  • The model was successfully applied to identify protein targets associated with WADA prohibited classes.
  • The study provides a framework for predicting bioactivity for compounds lacking experimental data, encouraging future experimental validation.